Comparison of Allergen Immunotherapy Alone and in Conjunction With Turbinate Surgery for Nasal Obstruction in Perennial Allergic Rhinitis Patients
Annals of Otology, Rhinology & Laryngology · 2024
DOI: 10.1177/00034894241234593 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annals of Otology, Rhinology & Laryngology, 2024. Verfasst von Amaris Xin Jie Chong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Rhinology and Skull Base Research Group, St Vincent's Centre for Applied Medical Research, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Turbinates, Nasal Obstruction, Rhinitis, Allergic, Perennial. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background
Nasal obstruction, triggered by allergic rhinitis, often does not resolve with allergen-specific immunotherapy (AIT) alone, thus inferior turbinate reduction surgery (ITR) may be required. This study aims to investigate the impact of combined treatment on nasal obstruction, as evidence is currently limited. Methodology/Principal: A retrospective cohort study of perennial allergic rhinitis patients experiencing nasal obstruction and undergoing ≥12 months AIT was conducted. Two groups were derived, those undergoing AIT—with or without an ITR. Patient reported nasal obstruction (evaluated with questionnaires) and nasal airway function (Nasal Peak Inspiratory Flow [NPIF] and Nasal Airflow Resistance [NAR]) were monitored. The change from baseline to 12 months post-treatment in each group were compared.
Results
A total of 118 patients (33.71 ± 14.43 years, 41.5% female) were recruited, 72% had AIT and 28% AIT&ITR. At baseline, the AIT&ITR group had a higher level of nasal obstruction (>moderate%; 63.6% vs 52.9%, P = .048). Post treatment, AIT&ITR group reported greater reduction in nasal obstruction (>1 category change: 75.8% vs 48.2%, P = .002). Similarly, the AIT&ITR group had greater improvement in nasal function by NPIF (−13.9 ± 110.3 L/minute vs −3.4 ± 78.1 L/minute, P = .049) and NAR (−0.120 ± 0.342 Pa/cm³/second vs −0.093 ± 0.224 Pa/cm³/second, P = .050).
Conclusions
Allergic rhinitis patients, with moderate to severe nasal obstruction, who undergo combined AIT&ITR have greater relief of nasal obstruction and improved airflow analysis compared to AIT alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rhinology and Skull Base Research Group, St Vincent's Centre for Applied Medical Research, Sydney, NSW, Australia.
- Faculty of Medicine, University of New South Wales Sydney, Sydney, NSW, Australia.
- Woolcock Institute, University of Sydney, Sydney, Australia.
- Faculty of Medicine, Notre Dame University, Sydney, Australia.
- Department of Otolaryngology, Head and Neck Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
- Department of Otolaryngology, Head and Neck Surgery, Concord Repatriation General Hospital, Sydney, NSW, Australia.
ORCID-Profile: Amaris Xin Jie Chong, Raewyn G Campbell
Zitieren
APA
Chong, A. X. J., Alvarado, R., Rimmer, J., Campbell, R. G., Kalish, L., Png, L. H., & Harvey, R. J. (2024). Comparison of Allergen Immunotherapy Alone and in Conjunction With Turbinate Surgery for Nasal Obstruction in Perennial Allergic Rhinitis Patients. Annals of Otology, Rhinology & Laryngology. https://doi.org/10.1177/00034894241234593
Vancouver
Chong AXJ, Alvarado R, Rimmer J, Campbell RG, Kalish L, Png LH, et al. Comparison of Allergen Immunotherapy Alone and in Conjunction With Turbinate Surgery for Nasal Obstruction in Perennial Allergic Rhinitis Patients. Annals of Otology, Rhinology & Laryngology. 2024. doi:10.1177/00034894241234593
BibTeX
@article{Chong2024,
author = {Chong, Amaris Xin Jie and Alvarado, Raquel and Rimmer, Janet and Campbell, Raewyn G and Kalish, Larry and Png, Lu Hui and Harvey, Richard J},
title = {Comparison of Allergen Immunotherapy Alone and in Conjunction With Turbinate Surgery for Nasal Obstruction in Perennial Allergic Rhinitis Patients},
journal = {Annals of Otology, Rhinology & Laryngology},
year = {2024},
doi = {10.1177/00034894241234593}
}
EUVIMED